This Overview has been created by the Life Sciences Asia Pacific Network, of which Corrs is a member. It contains Australia-specific content by Eugenia Kolivos (Partner), Isaac Lin (Special Counsel) & Heather Curd (Senior Associate).
For many years, emerging markets have been strategically important for the growth and development of the Lifesciences sector. Almost 90% of the sector now operates in an emerging market, including the Asia-Pacific region.
The Life Sciences Asia Pacific Network has prepared this guide, which gives a comparative overview of the distribution and marketing of drugs in Australia, China, India, Indonesia, Japan, Korea, Singapore, Taiwan, Thailand and Vietnam. It also highlights the key legal and commercial issues to consider when doing business in the region.
You can access a copy of A Comparative overview of Distribution and Marketing of Drugs across Asia-Pacific here, or click the ‘DOWNLOAD PDF’ button.
A Comparative overview of Distribution and Marketing of Drugs across Asia-Pacific (Overview), is a publication of the Life Sciences Asia Pacific Network. The Overview is published by CMS, and reproduced with its permission.
The Overview provides information and comments on legal issues and developments of interest to our clients and friends. It is not a comprehensive treatment of the subject matter covered and is not intended to provide legal advice. Readers should seek legal advice before taking any action with respect to the matters discussed in the Overview.
This publication is introductory in nature. Its content is current at the date of publication. It does not constitute legal advice and should not be relied upon as such. You should always obtain legal advice based on your specific circumstances before taking any action relating to matters covered by this publication. Some information may have been obtained from external sources, and we cannot guarantee the accuracy or currency of any such information.